# Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder

> **NCT01512004** · PHASE3 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 324 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Propiverine Hydrochloride
- **DRUG:** Tolterodine Extended-release Tablet

## Key facts

- **NCT ID:** NCT01512004
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-01
- **Final completion:** 2011-08
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2012-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01512004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01512004, "Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01512004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*